Is iron-overload an independent prognostic factor in AML and MDS patients undergoing allogeneic stem cell transplantation?

被引：0
|
作者：
Wermke, M. [1 ]
Schmidt, A. [1 ]
Middeke, M. [1 ]
Sockel, K. [1 ]
von Bonin, M. [1 ]
Schoenefeldt, C. [1 ]
Plodeck, V [2 ]
Laniado, M. [2 ]
Schetelig, J. [1 ]
Ehninger, G. [1 ]
Bornhaeuser, M. [1 ]
Platzbecker, U. [1 ]
机构：
[1] Univ Klin Dresden, Med Klin 1, Dresden, Germany
[2] Univ Klin Dresden, Inst Radiol, Dresden, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [41] Dose-reduced conditioning followed by allogeneic stem cell transplantation in patients with MDS or secondary AML
    Kröger, N
    Schwerdtfeger, R
    Bornhäuser, M
    Ehninger, G
    Runde, V
    Beyer, J
    Kiehl, M
    Schetelig, J
    Siegert, W
    Schäfer-Eckert, K
    Wandt, H
    Sayer, HG
    Kröger, M
    Zabelina, T
    Zander, AR
    BONE MARROW TRANSPLANTATION, 2002, 29 : S57 - S57
  • [42] The outcome of allogeneic stem cell transplantation in patients with high risk MDS and AML: single center experience
    Halahleh, Khalid
    Odaily, Sarah
    Al Tell, Abdallah
    Al-Awabdeh, Tala
    Ma'kosa, Mohammad
    Najjar, Rula
    Rihani, Rawad
    Abu Shanab, Mayada
    Hussein, Nilly
    Khattab, Eman
    Sharma, Shanta
    Abu Khader, Ahmad
    Yousef, Dana
    Abu-Jazar, Husam
    Tbakhi, Abdelghani
    Sarhan, Mahmoud
    BONE MARROW TRANSPLANTATION, 2018, 53 : 189 - 190
  • [43] Bone marrow fibrosis on outcomes of patients with MDS/sAML undergoing allogeneic stem cell transplantation
    Kroeger, N.
    Zabelina, T.
    van Biezen, A.
    Brand, R.
    de Witte, T.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S62 - S62
  • [44] Iron Overload during Transplantation affects the Survival of MDS- and AML-Patients
    Nothing, Pia
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2016, 43 (02) : 142 - 142
  • [45] Symptom burden in patients undergoing allogeneic blood or marrow transplantation for AML/MDS.
    Williams, L
    Wang, XS
    Cleeland, C
    Giralt, S
    ONCOLOGY NURSING FORUM, 2006, 33 (02) : 410 - 410
  • [46] Prognostic factors for allogeneic stem cell transplantation (ASCT) for refractory acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).
    Wong, R
    Shahjahan, M
    De Lima, M
    Anagnostopoulos, A
    Estey, E
    Champlin, R
    Andersson, B
    Khouri, I
    Giralt, S
    BLOOD, 2002, 100 (11) : 853A - 853A
  • [47] Prognostic Impact of Iron Overload During Follow-up After Allogeneic Stem Cell Transplantation
    Meyer, Sara C.
    Buser, Andreas S.
    Tichelli, Andre
    Passweg, Jakob R.
    Stern, Martin
    BLOOD, 2011, 118 (21) : 163 - 164
  • [48] Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS
    Nakamura, Sousuke
    Yokoyama, Kazuaki
    Shimizu, Eigo
    Yusa, Nozomi
    Kondoh, Kanya
    Ogawa, Miho
    Takei, Tomomi
    Kobayashi, Asako
    Ito, Mika
    Isobe, Masamichi
    Konuma, Takaaki
    Kato, Seiko
    Kasajima, Rika
    Wada, Yuka
    Nagamura-Inoue, Tokiko
    Yamaguchi, Rui
    Takahashi, Satoshi
    Imoto, Seiya
    Miyano, Satoru
    Tojo, Arinobu
    BLOOD, 2019, 133 (25) : 2682 - 2695
  • [49] The prognostic relevance of the knowledge bank approach in patients with acute myeloid leukemia (AML) undergoing allogeneic stem cell transplantation (HSCT)
    Schwind, S.
    Herrmann, L.
    Bischof, L.
    Backhaus, D.
    Brauer, D.
    Franke, G. -N.
    Vucinic, V.
    Platzbecker, U.
    Jentzsch, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 240 - 240
  • [50] Upfront allogeneic hematopoietic stem cell transplantation for patients with MDS
    Schaefer-Eckart, K.
    Wiener, S.
    Wendelin, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 137 - 137
12345